At the end of the second quarter of 2015, the hedge fund M&R Capital Management Inc, reported a total value of its portfolio of $422.9 million with a increase of $15,000 over the previous quarter.
During Q2 2015, the hedge fund bought nine new stocks and increased 30 of its stakes. The following are the most heavily weighted buys during the quarter.
It bought shares of Allergan PLC (AGN) with an impact of 3.29% on its portfolio. The company is engaged in development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products. It also develops and out-license generic pharmaceutical products in Europe through its Medis third-party business. It operates in three segments, Pharma, Specialty Brands and Anda Distribution.
Allergan has a profitability and growth rating of 7 out of 10 with negative returns (ROE -6.23%, ROA -3.09%) that are underperforming 75% of the Global Drug Manufacturers - Specialty & Generic industry. Margins are also negative: operating margin and net margin are negative respectively -12,22% and -14.27%. Financial strength has a rating of 6 out of 10 with a weak cash to debt of 0.04 that is very low if compared to the industry median of 2.66.
The price of the stock has risen by 632% during the last 5 years and 21% year-to-date, but has dropped by 44% during the last 12 months. The current price is -7.59% from its 52-week high and +50.74% from its 52-week low.
During the last quarter, the company reported net revenue increasing by 116% and on a non-GAAP basis, diluted earnings per share increased 29% compared to the same quarter of a year before. Also, they achieved important R&D milestones that will help fuel both their branded and generics businesses in the future.
The main hedge fund holding shares of the company is Vanguard Health Care Fund (Trades, Portfolio) with 2.30% of outstanding shares, followed by John Paulson (Trades, Portfolio) with 1.82% and Andreas Halvorsen (Trades, Portfolio) with 1.73%.
It bought shares of Citizens Financial Group Inc (CFG) with an impact of 2.07% on its portfolio.The company, through its subsidiaries, provides retail and commercial banking products and services. It operates its business through two operating segments: Consumer Banking and Commercial Banking.
The company has a profitability and growth rating of 4 out of 10 with easy positive returns (ROE 4.03%, ROA 0.59%) that are underperforming 80% of the Global Banks - Regional - US industry. Weak returns are not affecting margins; operating margin is 24.43% and net margin is 16.62%. Financial strength has a rating of 5 out of 10 with an interest coverage of 3.49, and a cash to debt of 0.29 that is ranked lower than 77% of CFG’s competitors. The industry has an average cash to debt ratio of 1.48.
The price of the stock has risen by 14% during the last 5 years, 7% since the beginning of the year and by 14% during the last 12 months. The current price is -8.12% from its 52-week high and +23.56% from its 52-week low.
Second quarter 2015 net income was down $19 million from first quarter and diluted EPS was down $0.03 from the first quarter 2015. But the revenue of the company rose by 1.4% driven by a slight increase in net interest income and strong growth in non-interest income.
The main hedge fund holding shares of the company is HOTCHKIS & WILEY with 3.25% of outstanding shares, followed by Chris Davis (Trades, Portfolio) with 2.71% and David Einhorn (Trades, Portfolio) with 2.38%.
It bought shares of Fastenal Co (FAST) with an impact of 0.06% on its portfolio. The company sells industrial and construction supplies to end-users and also have some 'walk-in' retail business. It operates 14 distribution centers in North America from which it distributes products to its store and in-plant locations.
The company has a profitability and growth rating of 8 out of 10 with strong returns such as ROE 27.90%, ROA 21.80% that are outperforming 96% of the Global Industrial Distribution industry. Margins are positive; operating margin is 21.55% and net margin is 13.47% and they are ranked higher than 91% of the company’s competitors. Financial strength is strong as well, with a rating of 9 out of 10 thanks to an interest coverage of 860.75, and a strong cash to debt of 1.52 that is high if compared to FAST’s industry, which has an average cash to debt ratio of 0.76.
The price of the stock has risen by 62% during the last 5 years, but has dropped by 15% since the beginning of the year and by 10% during the last 12 months. The current price is -16.97% from its 52-week high and +1.90% from its 52-week low.
In the second quarter, revenues rose 5% year over year to $997.8 million; even so, this lagging revenue was the result of a slump in demand from the oil and gas producing sector, failed to meet analysts' $1 billion revenue expectations for the quarter.
The main shareholder of the company is Ruane Cunniff (Trades, Portfolio) with 8.27% of outstanding shares, followed by Ron Baron (Trades, Portfolio) with 1.30% and Bill Frels (Trades, Portfolio) with 0.75%.
It bought shares of Cigna Corp (CI) with an impact of 0.06% on its portfolio. The company is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. The Company's segments are Global Health Care, Group Disability and Life, Global Supplemental Benefits, Run-off Reinsurance and Other Operations including Corporate-owned Life Insurance.
The company has a profitability and growth rating of 7 out of 10 with positive returns: ROE of 19.26% is outperforming 81% of the Global Health Care Plans industry, and ROA of 3.75% is ranked higher than 59% of other companies in the same sector. Financial strength has a rating of 6 out of 10 with an interest coverage of 12.47, and a weak cash to debt of 0.38 that is very low if compared to the industry median of 1.81.
The price of the stock has risen by 327% during the last 5 years, by 40% since the beginning of the year and by 55% during the last 12 months. The current price is -15.56% from its 52-week high and +68.07% from its 52-week low.
In the second quarter, consolidated revenues increased by 9% while adjusted income had growth of 23% per shares compared to the same quarter of a year before. The strong second quarter results can reflect the consistent effective execution of their global strategy.
The main hedge fund holding shares of the company is Dodge & Cox with 3.98% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 2.26% and the shareholder Andreas Halvorsen (Trades, Portfolio) with 1.13%.
It bought shares of Chicago Bridge & Iron Company (CBI) with an impact of 0.06% on its portfolio. The company provides conceptual design, technology, engineering, procurement, fabrication, modularization, construction, commissioning, maintenance, program management and environmental services to customers in the energy infrastructure market throughout the world, and is a provider of diversified government services.
The company has a profitability and growth rating of 7 out of 10 with good returns (ROE 22.11%, ROA 6.38%) that are outperforming 79% of the Global Engineering & Construction industry. Financial strength has a rating of 7 out of 10 with an interest coverage of 11.76, and a weak cash to debt of 0.16 that is very low if compared to the industry median of 0.73
The price of the stock has risen by 134% during the last 5 years, by 23% since the beginning of the year but dropped by 13% during the last 12 months. The current price is -20.80% from its 52-week high and +61.01% from its 52-week low.
In its first quarter as a result of progress on their large U.S. nuclear projects, increased LNG activity in the U.S. and higher plant maintenance revenue, revenues for the first quarter had increased about 7% compared to the same quarter of a year before.
The main shareholder holding shares of the company is Warren Buffett (Trades, Portfolio) with 8.76% of outstanding shares, followed by David Einhorn (Trades, Portfolio) with 6.32% and David Tepper (Trades, Portfolio) with 1.13%.
Increased stakes
The company also increased 30 of its stakes, and the most important are the following: Apple Computer Inc (AAPL) by 8%, Union Pacific Corp (UNP) by 5%, Omega Healthcare Inv Inc (OHI) by 13%, Kayne Anderson Mlp Invt Co (KYN) by 16%, Intel Corp (INTC) by 6.67%, United Rentals Inc (URI) by 638.76% and Spectra Energy Corp (SE) by 5.59%.
